查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1637064

益生菌菌株的全球市场 - 全球产业分析，规模，占有率，成长，趋势，预测(2032年)

Probiotic Strains Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
出版日期: | 出版商: Fairfield Market Research | 英文 152 Pages | 商品交期: 2-5个工作天内

价格
简介目录

随着消费者对肠道健康及其与整体健康的关係的认识不断提高，全球益生菌菌株市场规模正在显着增长。预计复合年增长率为 8.10%，市场规模将从 2025 年的 65.4 亿美元扩大到 2032 年的 112.8 亿美元。这一增长证实了各行业对富含益生菌的产品的需求不断增加。

益生菌菌株是有益的微生物，包括细菌和酵母，可支持消化系统健康并改善整体健康。市场专注于利用这些菌株来解决特定的健康问题，增强免疫力并提供自然的预防性医疗保健方法。益生菌研究和产品多样化的创新继续推动市场成长，其应用涵盖膳食补充剂、功能性食品以及食品和饮料。

受消费者对健康生活方式、科学进步和创新应用的兴趣的推动，益生菌菌株市场有望实现动态成长。专注于永续性、法规合规性和个人化解决方案的公司将能够抓住新机会并引领市场发展。益生菌菌株市场发展前景光明，并有望在塑造未来的健康和保健方面发挥关键作用。

对肠道微生物群在整体健康中的作用的认识不断提高，推动了对益生菌的需求。消费者正在积极寻求有助于消化、增强免疫力和解决肠道相关问题的产品。正在进行的研究可以客製化菌株以解决特定的健康问题，提供客製化解决方案并增强消费者对益生菌产品的信心。

本报告提供全球益生菌菌株市场相关调查，提供市场概要，以及各类型，各形态，各最终用途，及各地区趋势，及市场参与市场企业的竞争趋势等资讯。

目录

第1章 摘要整理

第2章 市场概要

  • 市场定义和市场区隔
  • 市场动态
  • 价值链分析
  • 波特的五力分析
  • COVID-19影响分析
  • 乌克兰·俄罗斯纠纷的影响
  • 经济概要
  • 大环境分析

第3章 全球益生菌菌株市场预测，2019年～2032年

  • 全球益生菌菌株市场预测，各类型，金额(10亿美元)，2019年～2032年
  • 全球益生菌菌株市场预测，各形态，价值(10亿美元)，2019年～2032年
  • 全球益生菌菌株市场预测，各最终用途，金额(10亿美元)，2019年～2032年
  • 全球益生菌菌株市场预测，各地区，金额(10亿美元)，2019年～2032年

第4章 北美的益生菌菌株市场预测，2019年～2032年

第5章 欧洲的益生菌菌株市场预测，2019年～2032年

第6章 亚太地区的益生菌菌株市场预测，2019年～2032年

第7章 南美的益生菌菌株市场预测，2019年～2032年

第8章 中东·非洲的益生菌菌株市场预测，2019年～2032年

第9章 竞争情形

  • 各最终用途vs各形态热图
  • 企业市场占有率分析，2025年
  • 竞争仪表板
  • 企业简介
    • Hansen Holding A/S
    • Probi
    • Aumgene Bioscience
    • Virchow Biotech Private Limited
    • Merck KGaA
    • I. du Pont de Nemours and Company
    • Koninklijke DSM N.V.
    • Ganeden
    • Lesaffre
    • Essum AB
    • Valio Dairy
    • BioGaia
    • Morinaga Milk Industry Co., Ltd

第10章 附录

简介目录

The global probiotic strains market is experiencing significant growth, driven by rising consumer awareness of gut health and its connection to overall well-being. With a projected compound annual growth rate (CAGR) of 8.10%, the market is set to expand from $6.54 billion in 2025 to $11.28 billion by 2032. This growth underscores the increasing demand for probiotic-rich products across various sectors.

Market Insights

Probiotic strains refer to beneficial microorganisms, including bacteria and yeast, that support digestive health and enhance overall wellness. The market focuses on leveraging these strains to address specific health concerns, boost immunity, and provide a natural approach to preventive healthcare. Innovations in probiotic research and product diversification continue to fuel market growth, with applications spanning dietary supplements, functional foods, and beverages.

The probiotic strains market is positioned for dynamic growth, driven by consumer interest in health-conscious lifestyles, scientific advancements, and innovative applications. Companies that focus on sustainability, regulatory compliance, and personalized solutions will be well-placed to capture emerging opportunities and lead the market's evolution. With its promising trajectory, the probiotic strains market is set to play a crucial role in shaping the future of health and wellness.

Key Market Drivers

  • 1. Rising Consumer Awareness and Health Consciousness: Increasing understanding of the gut microbiota's role in overall health has driven demand for probiotics. Consumers are actively seeking products to support digestion, boost immunity, and address gut-related issues.
  • 2. Scientific Advancements in Probiotics: Ongoing research has enabled the customization of strains to target specific health concerns, offering tailored solutions and boosting consumer confidence in probiotic products.

Business Opportunities

  • 1. Diversification of Applications: Probiotic strains are increasingly being incorporated into functional foods, beverages, and even pet nutrition. These new applications cater to the rising trend of health-conscious lifestyles.
  • 2. Personalized Probiotics: Advancements in microbiome research allow for tailored probiotic formulations that align with individual health profiles, offering targeted benefits and tapping into the personalized healthcare trend.

Market Restraints

  • 1. Regulatory Challenges: Varying regulatory frameworks across regions pose significant hurdles for market entry and compliance, emphasizing the need for harmonized guidelines.
  • 2. Sustainability Concerns: Resource-intensive production processes highlight the need for eco-friendly solutions to balance demand with environmental sustainability.

Regional Analysis

  • 1. Europe: The region dominates the market due to a robust R&D infrastructure, stringent quality standards, and a strong emphasis on preventive healthcare. The demand for probiotic-enriched functional foods and supplements is particularly high.
  • 2. South Asia & Oceania: This region represents the fastest-growing market, driven by increasing consumer awareness and a rising population adopting probiotic-rich diets.

Recent Developments

  • 1. KeVita Expands Probiotic Beverages Line: In January 2023, KeVita launched mango-flavored Sparkling Probiotic Lemonade, available in major US retail chains. This expansion enhances market penetration by catering to diverse consumer tastes.
  • 2. Nestle Enters Chinese Market: In September 2022, Nestle Garden of Life introduced its first probiotic product in China's infant food category, addressing the growing demand for early-life health solutions.
  • 3. BioGaia Launches Respiratory Health Probiotic: In July 2022, BioGaia Pharax debuted in the UK, reflecting the industry's focus on expanding probiotic applications beyond digestive health.

Key Players Prominent companies driving innovation in the probiotic strains market include:

  • Hansen Holding A/S
  • Probi
  • Aumgene Bioscience
  • Virchow Biotech Private Limited
  • Merck KGaA
  • Koninklijke DSM N.V.
  • BioGaia
  • Morinaga Milk Industry Co., Ltd.

These companies are leveraging competitive intelligence, strategic collaborations, and product diversification to strengthen their market positions.

Market Segmentation

1. By Type:

    Lactobacillus acidophilus (dominant due to its proven efficacy in gut health) Lactobacillus rhamnosus GG Bifidobacterium bifidum (fastest-growing category) Others

2. By Form:

    Dry (dominant due to stability and versatility) Liquid (fast-growing, driven by consumer preference for innovative formulations)

3. By End-use Application:

    Dietary Supplements (largest segment) Functional Foods (fastest-growing segment) Pharmaceuticals Animal Feed Food and Beverages (e.g., yogurt drinks, fermented milk, and bakery items)

4. By Region:

    North America Europe East Asia South Asia & Oceania Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Probiotic Strains Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2025
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Probiotic Strains Market Outlook, 2019 - 2032

  • 3.1. Global Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Lactobacillus acidophilus
      • 3.1.1.2. Lactobacillus rhamnoses GG
      • 3.1.1.3. Bifidobacterium bifidum
      • 3.1.1.4. Others
  • 3.2. Global Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Dry
      • 3.2.1.2. Liquid
  • 3.3. Global Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Food and Beverages
      • 3.3.1.2. Yogurt Drink and Fermented Milk
      • 3.3.1.3. Fruit Juice
      • 3.3.1.4. Bakery
      • 3.3.1.5. Meat Products
      • 3.3.1.6. Pharmaceuticals
      • 3.3.1.7. Functional Food
      • 3.3.1.8. Animal Feed
      • 3.3.1.9. Dietary Supplement
  • 3.4. Global Probiotic Strains Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Probiotic Strains Market Outlook, 2019 - 2032

  • 4.1. North America Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Lactobacillus acidophilus
      • 4.1.1.2. Lactobacillus rhamnoses GG
      • 4.1.1.3. Bifidobacterium bifidum
      • 4.1.1.4. Others
  • 4.2. North America Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Dry
      • 4.2.1.2. Liquid
  • 4.3. North America Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Food and Beverages
      • 4.3.1.2. Yogurt Drink and Fermented Milk
      • 4.3.1.3. Fruit Juice
      • 4.3.1.4. Bakery
      • 4.3.1.5. Meat Products
      • 4.3.1.6. Pharmaceuticals
      • 4.3.1.7. Functional Food
      • 4.3.1.8. Animal Feed
      • 4.3.1.9. Dietary Supplement
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis
  • 4.4. North America Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.2. Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 4.4.1.3. Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 4.4.1.4. Canada Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 4.4.1.5. Canada Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 4.4.1.6. Canada Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Probiotic Strains Market Outlook, 2019 - 2032

  • 5.1. Europe Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Lactobacillus acidophilus
      • 5.1.1.2. Lactobacillus rhamnoses GG
      • 5.1.1.3. Bifidobacterium bifidum
      • 5.1.1.4. Others
  • 5.2. Europe Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Dry
      • 5.2.1.2. Liquid
  • 5.3. Europe Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Food and Beverages
      • 5.3.1.2. Yogurt Drink and Fermented Milk
      • 5.3.1.3. Fruit Juice
      • 5.3.1.4. Bakery
      • 5.3.1.5. Meat Products
      • 5.3.1.6. Pharmaceuticals
      • 5.3.1.7. Functional Food
      • 5.3.1.8. Animal Feed
      • 5.3.1.9. Dietary Supplement
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. Europe Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.2. Germany Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. Germany Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. U.K. Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.5. U.K. Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. U.K. Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.7. France Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.8. France Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.9. France Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.10. Italy Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.11. Italy Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.12. Italy Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.13. Turkey Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.14. Turkey Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.15. Turkey Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.16. Russia Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.17. Russia Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.18. Russia Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 5.4.1.19. Rest of Europe Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 5.4.1.20. Rest of Europe Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 5.4.1.21. Rest of Europe Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Probiotic Strains Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Lactobacillus acidophilus
      • 6.1.1.2. Lactobacillus rhamnoses GG
      • 6.1.1.3. Bifidobacterium bifidum
      • 6.1.1.4. Others
  • 6.2. Asia Pacific Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Dry
      • 6.2.1.2. Liquid
  • 6.3. Asia Pacific Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Food and Beverages
      • 6.3.1.2. Yogurt Drink and Fermented Milk
      • 6.3.1.3. Fruit Juice
      • 6.3.1.4. Bakery
      • 6.3.1.5. Meat Products
      • 6.3.1.6. Pharmaceuticals
      • 6.3.1.7. Functional Food
      • 6.3.1.8. Animal Feed
      • 6.3.1.9. Dietary Supplement
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Asia Pacific Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.2. China Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. China Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. Japan Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.5. Japan Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. Japan Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. South Korea Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.8. South Korea Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. South Korea Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. India Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.11. India Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. India Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Southeast Asia Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.14. Southeast Asia Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Southeast Asia Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Rest of Asia Pacific Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 6.4.1.17. Rest of Asia Pacific Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Rest of Asia Pacific Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Probiotic Strains Market Outlook, 2019 - 2032

  • 7.1. Latin America Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Lactobacillus acidophilus
      • 7.1.1.2. Lactobacillus rhamnoses GG
      • 7.1.1.3. Bifidobacterium bifidum
      • 7.1.1.4. Others
  • 7.2. Latin America Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Dry
      • 7.2.1.2. Liquid
  • 7.3. Latin America Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Food and Beverages
      • 7.3.1.2. Yogurt Drink and Fermented Milk
      • 7.3.1.3. Fruit Juice
      • 7.3.1.4. Bakery
      • 7.3.1.5. Meat Products
      • 7.3.1.6. Pharmaceuticals
      • 7.3.1.7. Functional Food
      • 7.3.1.8. Animal Feed
      • 7.3.1.9. Dietary Supplement
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Latin America Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.2. Brazil Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. Brazil Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Mexico Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.5. Mexico Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Mexico Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. Argentina Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.8. Argentina Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. Argentina Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. Rest of Latin America Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 7.4.1.11. Rest of Latin America Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. Rest of Latin America Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Probiotic Strains Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Probiotic Strains Market Outlook, by Type, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Lactobacillus acidophilus
      • 8.1.1.2. Lactobacillus rhamnoses GG
      • 8.1.1.3. Bifidobacterium bifidum
      • 8.1.1.4. Others
  • 8.2. Middle East & Africa Probiotic Strains Market Outlook, by Form, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Dry
      • 8.2.1.2. Liquid
  • 8.3. Middle East & Africa Probiotic Strains Market Outlook, by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Food and Beverages
      • 8.3.1.2. Yogurt Drink and Fermented Milk
      • 8.3.1.3. Fruit Juice
      • 8.3.1.4. Bakery
      • 8.3.1.5. Meat Products
      • 8.3.1.6. Pharmaceuticals
      • 8.3.1.7. Functional Food
      • 8.3.1.8. Animal Feed
      • 8.3.1.9. Dietary Supplement
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Middle East & Africa Probiotic Strains Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.2. GCC Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. GCC Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. South Africa Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.5. South Africa Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. South Africa Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Egypt Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.8. Egypt Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Egypt Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Nigeria Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.11. Nigeria Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Nigeria Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
      • 8.4.1.13. Rest of Middle East & Africa Probiotic Strains Market by Type, Value (US$ Bn), 2019 - 2032
      • 8.4.1.14. Rest of Middle East & Africa Probiotic Strains Market by Form, Value (US$ Bn), 2019 - 2032
      • 8.4.1.15. Rest of Middle East & Africa Probiotic Strains Market by End Use Application, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By End Use Application vs by Form Heat map
  • 9.2. Company Market Share Analysis, 2025
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Hansen Holding A/S
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Probi
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. Aumgene Bioscience
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Virchow Biotech Private Limited
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Merck KGaA
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. I. du Pont de Nemours and Company
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. Koninklijke DSM N.V.
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Ganeden
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development
    • 9.4.9. Lesaffre
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Development
    • 9.4.10. Essum AB
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Development
    • 9.4.11. Valio Dairy
      • 9.4.11.1. Company Overview
      • 9.4.11.2. Product Portfolio
      • 9.4.11.3. Financial Overview
      • 9.4.11.4. Business Strategies and Development
    • 9.4.12. BioGaia
      • 9.4.12.1. Company Overview
      • 9.4.12.2. Product Portfolio
      • 9.4.12.3. Financial Overview
      • 9.4.12.4. Business Strategies and Development
    • 9.4.13. Morinaga Milk Industry Co., Ltd
      • 9.4.13.1. Company Overview
      • 9.4.13.2. Product Portfolio
      • 9.4.13.3. Financial Overview
      • 9.4.13.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations